Hypertension associated with oral administration of physostigmine in a patient with Alzheimer's disease.
The hemodynamic effects of physostigmine, a cholinomimetic drug used in the experimental treatment of Alzheimer's disease, are largely unknown. The author describes the development of episodes of hypertension in an elderly patient with Alzheimer's disease following treatment with oral physostigmine.
D000284:Administration, Oral; D000368:Aged; D000544:Alzheimer Disease / Q000188:drug therapy*; D005260:Female; D006801:Humans; D006973:Hypertension / Q000139:chemically induced*; D010830:Physostigmine / Q000008:administration & dosage / Q000009:adverse effects*
D010830:Physostigmine